Tyrogenex, a privately held company focused on the development of targeted therapeutics for cancer and ophthalmology, today announced data from its phase 1 open-label study of orally-administered X-82 in patients for wet age-related macular degeneratio…
ALPHAEON signs agreement with PhysIOL to develop and commercialize Trifocal lens technology
ALPHAEON Corporation today announced it has entered into a definitive agreement with PhysIOL SA of Belgium, to jointly develop and commercialize an exclusive ALPHAEON-branded Trifocal lens technology. Specific terms of the agreement were not disclosed.
Ranibizumab may become reasonable treatment alternative for patients with proliferative diabetic retinopathy
Among patients with proliferative diabetic retinopathy, treatment with an injection in the eye of the drug ranibizumab resulted in visual acuity that was not worse than panretinal photocoagulation at 2 years, according to a study appearing in JAMA.
Study: Programmable electronic glasses help improve vision in children diagnosed with lazy eye
A new study on lazy eye found that programmable electronic glasses help improve vision in children just as well as the more traditional treatment using eye patches. This “digital patch” is the first new effective treatment for lazy eye in half a centur…
Medflow announces availability of advanced cloud-based EHR system
Medflow, Inc., the leading electronic health record (EHR) and practice management solutions provider for ophthalmologists, announced today the availability of Medflow 2.0 EHR, its most advanced cloud-based EHR system. Medflow 2.0 EHR streamlines the en…
Speaker calls for prospective studies of donor diabetes and keratoplasty outcomes
LAS VEGAS — Because the effect of donor diabetes history on keratoplasty outcomes is unknown, there is a need for prospective studies to manage its impact, according to a presentation here. Jonathan Lass, MD, discussed the growing problem of the impact of donor diabetes on the future of the cornea donor pool and patients requiring keratoplasty at the American Academy of Ophthalmology annual meeting.